E. Ohman J:or Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39M Buy
77,885
+814
+1% +$391K 0.91% 26
2026
Q1
$37.9M Sell
77,071
-15,998
-17% -$8.68M 1% 23
2025
Q4
$53.9M Sell
93,069
-11,292
-11% -$6.39M 1.26% 13
2025
Q3
$50.6M Buy
104,361
+18,686
+22% +$8.7M 1.19% 15
2025
Q2
$34.7M Buy
85,675
+15,064
+21% +$6.3M 0.86% 26
2025
Q1
$35.1M Sell
70,611
-14,252
-17% -$7.72M 0.93% 28
2024
Q4
$44.1M Buy
84,863
+2,087
+3% +$1.15M 1.03% 22
2024
Q3
$51.2M Sell
82,776
-2,316
-3% -$1.37M 1.27% 19
2024
Q2
$47.1M Buy
85,092
+1,093
+1% +$626K 1.17% 19
2024
Q1
$48.8M Sell
83,999
-7,472
-8% -$4.19M 1.24% 18
2023
Q4
$48.6M Buy
91,471
+28,930
+46% +$14M 1.78% 10
2023
Q3
$31.7M Sell
62,541
-2,113
-3% -$1.13M 1.19% 21
2023
Q2
$33.7M Buy
64,654
+3,849
+6% +$2.08M 1.22% 18
2023
Q1
$35M Buy
60,805
+2,043
+3% +$1.15M 1.37% 15
2022
Q4
$32.4M Sell
58,762
-12,905
-18% -$6.84M 1.41% 18
2022
Q3
$36.3M Buy
71,667
+6,532
+10% +$3.66M 1.66% 10
2022
Q2
$35.4M Sell
65,135
-20,800
-24% -$11.4M 1.53% 14
2022
Q1
$50.8M Buy
85,935
+4,052
+5% +$2.33M 1.7% 10
2021
Q4
$54.6M Sell
81,883
-23,050
-22% -$14.4M 1.58% 11
2021
Q3
$60M Hold
104,933
1.88% 8
2021
Q2
$52.9M Buy
104,933
+20,230
+24% +$9.55M 1.66% 10
2021
Q1
$38.7M Sell
84,703
-1,105
-1% -$527K 1.4% 17
2020
Q4
$40M Sell
85,808
-16,892
-16% -$7.92M 1.63% 14
2020
Q3
$45.3M Sell
102,700
-140
-0.1% -$57.8K 2.24% 8
2020
Q2
$37.3M Buy
102,840
+2,660
+3% +$892K 2.14% 10
2020
Q1
$28.4M Sell
100,180
-19,950
-17% -$6.29M 2.08% 11
2019
Q4
$39M Buy
120,130
+4,220
+4% +$1.28M 2.16% 10
2019
Q3
$33.8M Sell
115,910
-6,900
-6% -$1.98M 2.13% 10
2019
Q2
$36.1M Buy
122,810
+4,768
+4% +$1.31M 2.37% 11
2019
Q1
$32.3M Buy
118,042
+16,552
+16% +$4.12M 2.18% 13
2018
Q4
$22.7M Sell
101,490
-8,431
-8% -$1.98M 1.65% 15
2018
Q3
$26.8M Sell
109,921
-2,583
-2% -$594K 1.74% 14
2018
Q2
$23.3M Buy
112,504
+13,692
+14% +$2.91M 1.66% 14
2018
Q1
$20.4M Buy
98,812
+9,466
+11% +$1.99M 1.63% 13
2017
Q4
$17M Buy
89,346
+1,400
+2% +$268K 1.38% 17
2017
Q3
$16.6M Sell
87,946
-4,914
-5% -$890K 1.48% 15
2017
Q2
$16.2M Buy
92,860
+36,955
+66% +$6.21M 1.63% 10
2017
Q1
$8.59M Buy
55,905
+6,651
+14% +$1.02M 1.05% 21
2016
Q4
$6.95M Sell
49,254
-1,472
-3% -$217K 0.97% 24
2016
Q3
$8.07M Sell
50,726
-5,890
-10% -$908K 1.2% 17
2016
Q2
$8.37M Buy
56,616
+13,854
+32% +$2.04M 1.39% 13
2016
Q1
$6.05M Buy
42,762
+34,762
+435% +$4.66M 1.1% 17
2015
Q4
$1.13M Hold
8,000
0.2% 93
2015
Q3
$978K Hold
8,000
0.26% 78
2015
Q2
$1.04M Sell
8,000
-1,000
-11% -$130K 0.24% 90
2015
Q1
$1.21M Hold
9,000
0.28% 80
2014
Q4
$1.14M Hold
9,000
0.27% 83
2014
Q3
$1.1M Buy
9,000
+1,200
+15% +$146K 0.27% 82
2014
Q2
$920K Hold
7,800
0.23% 98
2014
Q1
$938K Sell
7,800
-1,200
-13% -$143K 0.23% 93
2013
Q4
$995K Hold
9,000
0.23% 92
2013
Q3
$829K Hold
9,000
0.21% 108
2013
Q2
$762K Buy
+9,000
New +$749K 0.21% 109

Other funds holding TMO

E. Ohman J:or Asset Management's TMO Position: Q2 2026 in Review

E. Ohman J:or Asset Management increased its Thermo Fisher Scientific (TMO) stake by 1.1% in Q2 2026, buying an estimated $391K and bringing the position to 77,885 shares worth $39M. The position accounts for 0.91% of the portfolio, ranked #26.

E. Ohman J:or Asset Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $60M in Q3 2021. 1,092 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • E. Ohman J:or Asset Management held 77,885 shares of Thermo Fisher Scientific worth $39M as of Q2 2026.
  • E. Ohman J:or Asset Management bought 814 Thermo Fisher Scientific shares in Q2 2026, an estimated $391K.
  • Thermo Fisher Scientific made up 0.91% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #26 holding.
  • E. Ohman J:or Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • E. Ohman J:or Asset Management's Thermo Fisher Scientific position peaked at $60M in Q3 2021.
  • 1,092 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.